Since the worldwide inoculation process is going strong, vaccine diplomacy has become a hot topic. In their quest for ensuring vaccine security, a report by The New York Times, based on the data on vaccine contracts compiled by Duke University, shows that the advance purchase contracts made by some advanced countries for potential vaccines would vaccinate their population many times: the European Union, two times, the United States and the United Kingdom, four times, and Canada, six times. The expectation that an early vaccination will bring back normalcy and a required push to economic growth fuelled many advanced countries to engage in vaccine battles. The arguments of public good and global cooperation have gone out of the window now. While advanced countries have turned their back on the need of poor countries to access COVID-19 vaccines, India has displayed empathy to their needs. India has taken a position that a significant percentage of the approved doses will be permitted for exports. While its exports to neighbouring countries will be under grant mode, initial shipment of vaccines to least developed countries will be free of cost. And, shipments of vaccines from India have already started reaching different parts of the developing world. While India is in its first phase of vaccination to cover health-care workers, exports from India are helping other countries also in initiating phase one of their vaccination programme, a gesture well appreciated globally. In a democracy, one can expect the backlash of sending vaccines abroad without vaccinating its population. Nevertheless, India’s approach only reinforces the need of having coordinated global efforts in bringing COVID-19 under control. This response manifests India’s unstinted commitment to global development and has consolidated its name as the world’s pharmacy. The attitude of India towards vaccinating the populations in the poorer countries has generated discussion in the richer countries about the necessity for more proactive measures to roll out vaccines to the developing nations.

Advanced purchase contracts of vaccines by developed countries are premised on hopes that